Latest / Oncology Today with Dr Neil Love
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer.
CME information and select publications here.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.